Authors: SCHAEFER HG TOUBLANC N WEIMANN HJ

Citation: Hg. Schaefer et al., THE PHARMACOKINETICS OF MOXONIDINE, Reviews in contemporary pharmacotherapy, 9(7), 1998, pp. 481-490

Authors: DEMOLIS JL MARTEL C FUNCKBRENTANO C SACHSE A WEIMANN HJ JAILLON P

Citation: Jl. Demolis et al., EFFECTS OF TEDISAMIL, ATENOLOL AND THEIR COMBINATION ON HEART AND RATE-DEPENDENT QT INTERVAL IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 44(4), 1997, pp. 403-409

Authors: WESNES K SIMPSON PM JANSSON B GRAHNEN A WEIMANN HJ KUPPERS H

Citation: K. Wesnes et al., MOXONIDINE AND COGNITIVE FUNCTION - INTERACTIONS WITH MOCLOBEMIDE ANDLORAZEPAM, European Journal of Clinical Pharmacology, 52(5), 1997, pp. 351-358

Authors: MENKE A WEIMANN HJ ACHTERT G SCHUSTER O MENKE G

Citation: A. Menke et al., ABSOLUTE BIOAVAILABILITY OF FOLIC-ACID FOLLOWING ORAL-ADMINISTRATION OF A FOLIC-ACID TABLET FORMULATION IN HEALTHY-VOLUNTEERS, Arzneimittel-Forschung, 44-2(9), 1994, pp. 1063-1067

Authors: MULLER M WEIMANN HJ EDEN G WEBER W MICHAELIS K DILGER C ACHTERT G

Citation: M. Muller et al., STEADY-STATE INVESTIGATION OF POSSIBLE PHARMACOKINETIC INTERACTIONS OF MOXONIDINE AND GLIBENCLAMIDE, European journal of drug metabolism and pharmacokinetics, 18(3), 1993, pp. 277-283